Austin, Texas 7/25/2007 9:48:08 PM
Speak with other shareholders about: (NYSE: AV), (Nasdaq: BRCD), (Nasdaq: CHTR), (Nasdaq: MVIS), and (NYSE: BSX) .
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the "Chat Live" button at the top.
Chat real-time with other investors about this AV news release, by clicking this link: http://www.stockwire.com/AV
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=AV
Avaya Inc. (NYSE: AV) down .88% on 15 million shares, yesterday released their third fiscal quarter 2007 revenues decreased 1.6 percent to $1.276 billion compared to $1.297 billion in the same period last year. Sales of products declined 1.6 percent, rental and managed services revenues declined 7.1 percent, and services revenues were flat. Foreign exchange benefited revenues by approximately $30 million, primarily in Europe. U.S. revenues declined 8 percent. EMEA revenues were relatively flat, with growth outside of Germany offset by declines within Germany. Asia Pacific revenues grew by 33 percent. Revenues in the Americas, non-U.S., grew by 11 percent, driven by performance in Latin America.
Chat real-time with other investors about this BRCD news release, by clicking this link: http://www.stockwire.com/BRCD
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=BRCD
Brocade (Nasdaq: BRCD), down 3% on 14 million shares, the leader in networked storage solutions that help enterprises connect and manage their information, yesterday announced that it has bolstered its Storage Area Network (SAN) management solutions with greater analytic and reporting capabilities in the Brocade SAN Health(TM) family of utilities, including full support for mainframe FICON(R) and McDATA SAN environments. Supporting more than 13,000 users to date, Brocade SAN Health Diagnostics Capture and Brocade SAN Health Professional are designed to improve operational efficiencies in both open systems and mainframe data center environments.
Chat real-time with other investors about this CHTR news release, by clicking this link: http://www.stockwire.com/CHTR
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=CHTR
Charter Communications, Inc. (NASDAQ: CHTR) down 4% on 13 million shares and Yellow Book USA today announced a co-marketing and distribution agreement for Charter Telephone(R) and Yellow Book product and service offerings. "With Yellow Book as a partner, we're increasing the awareness and visibility of Charter's commercial and residential telephone service," said Ted Schremp, senior vice president and general manager, Charter Telephone. "Yellow Book's sales representatives serve as a powerful channel to the small and medium-sized businesses we're targeting with Charter Telephone, enabling us to accelerate our recent entry into the commercial telephone business. At the same time, we're filling a demand for local directory information for residential customers." Microvision (Nasdaq: MVIS) up 12% on 12 million shares, yesterday announced that it has signed an agreement with Motorola to develop pico projector display solutions for mobile applications leveraging Microvision's ultra-miniature laser based display engine, called PicoP(TM).
Chat real-time with other investors about this BSX news release, by clicking this link: http://www.stockwire.com/BSX
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=BSX
Boston Scientific Corporation (NYSE: BSX) down 2% on 12 million shares, yesterday announced its intention to explore the sale of its fluid management business as part of the Company's ongoing review of its portfolio of assets. The Boston Scientific fluid management business, formerly North American Medical Instruments Corp. (NAMIC), produces a range of products used to manage fluid and measure pressure during angiography and angioplasty procedures. A sale would be expected to include the business as well as the Company's facilities in Glens Falls, New York and Tullamore, Ireland.
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire: Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm For further information, please contact:The Stockwire Group Tel: +1 512 358 8440 e-mail: info@stockwire.com
Release date: 25 Jul 2007